NeueHealth, Inc. (NEUE)
Oct 2, 2025 - NEUE was delisted (reason: taken private)
6.75
+0.08 (1.24%)
Inactive · Last trade price on Oct 1, 2025
NeueHealth Revenue
NeueHealth had revenue of $209.08M in the quarter ending June 30, 2025, a decrease of -7.48%. This brings the company's revenue in the last twelve months to $890.44M, down -13.83% year-over-year. In the year 2024, NeueHealth had annual revenue of $936.66M, down -19.31%.
Revenue (ttm)
$890.44M
Revenue Growth
-13.83%
P/S Ratio
0.06
Revenue / Employee
$903,083
Employees
986
Market Cap
60.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 936.66M | -224.15M | -19.31% |
| Dec 31, 2023 | 1.16B | 409.64M | 54.53% |
| Dec 31, 2022 | 751.16M | -761.87M | -50.35% |
| Dec 31, 2021 | 1.51B | 998.15M | 193.86% |
| Dec 31, 2020 | 514.89M | 234.21M | 83.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNEUE News
- 4 weeks ago - NeueHealth Announces Closing of Take-Private Transaction - Business Wire
- 3 months ago - NeueHealth, Inc. (NEUE) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - NeueHealth Reports Second Quarter 2025 Results - Business Wire
- 3 months ago - NeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025 - Business Wire
- 6 months ago - NeueHealth, Inc (NEUE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - NeueHealth Reports First Quarter 2025 Results - Business Wire
- 7 months ago - NeueHealth to Host First Quarter 2025 Earnings Conference Call on May 8, 2025 - Business Wire
- 7 months ago - NEUEHEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeueHealth, Inc. - NEUE - Business Wire